spacer
home > ebr > winter 2018 > under lock and key
PUBLICATIONS
European Biopharmaceutical Review

Under Lock and Key

A new approach to early-stage drug development is being pioneered in Cambridge with the establishment of the Milner Therapeutics Institute (1). This collaboration between pharmaceutical companies and a number of academic institutions aims to create an ecosystem for pre-competitive drug discovery by sharing data and other resources. This initiative illustrates how the increasing volume and complexity of biodata is creating the need for new data management models to ensure that researchers can access the information they need, wherever it is stored, within a secure environment.

The Milner Institute has evolved from the research agreement signed in June 2015 between the University of Cambridge, the Wellcome Trust Sanger Institute and the Babraham Institute with the pharma companies AstraZeneca, Astex and GSK. The number of affiliates has since increased to 66 (2).

Having an agreement in place has lowered the barriers of engagement. Where previously the exchange of potential drug molecules between pharma and researchers could take a year, it now takes two to three weeks.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Misha Kapushesky is founder and Chief Executive Officer of biodata management company Genestack. Prior to Genestack, he was Team Leader in Functional Genomics at the European Bioinformatics Institute (EBI), where he led a team developing pioneering bioinformatics data systems to manage and query the data EBI was archiving. The high level of industry interest made Misha realise these tools addressed a significant pain-point. Genestack has since worked closely with leading industry partners to build a bioinformatics infrastructure that makes it easy to find, combine, analyse and visualise data. Misha has participated in and led international consortia applying bioinformatics to medical research.

spacer
Dr Misha Kapushesky
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Announces Expansion of its Industry-Leading Cold Chain Infrastructure with Dedicated Minus 40 degrees C Facility

Philadelphia, USA – August 29, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, Clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce the completion of a purpose built -40°C storage and distribution facility at its North American Clinical Services Center of Excellence.
More info >>

White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

 
Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europe’s Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont­ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement